These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8419774)

  • 61. Helicobacter pylori, gastric ulcer, and duodenal ulcer.
    Rubin CE
    N Engl J Med; 1996 Dec; 335(24):1841-2; author reply 1842-3. PubMed ID: 8965892
    [No Abstract]   [Full Text] [Related]  

  • 62. Omeprazole: short- and long-term safety.
    Yeomans ND
    Adverse Drug React Toxicol Rev; 1994; 13(3):145-56. PubMed ID: 7827223
    [No Abstract]   [Full Text] [Related]  

  • 63. Omeprazole: a novel antisecretory agent for the treatment of acid-peptic disorders.
    Lampkin TA; Ouellet D; Hak LJ; Dukes GE
    DICP; 1990 Apr; 24(4):393-402. PubMed ID: 2183494
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of omeprazole in patients with Zollinger-Ellison syndrome.
    Frucht H; Maton PN; Jensen RT
    Dig Dis Sci; 1991 Apr; 36(4):394-404. PubMed ID: 2007355
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.
    Stewart CA; Termanini B; Sutliff VE; Serrano J; Yu F; Gibril F; Jensen RT
    Aliment Pharmacol Ther; 1998 Jan; 12(1):83-98. PubMed ID: 9692706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of long-term omeprazole treatment.
    Pashankar DS
    Gastroenterology; 2000 Oct; 119(4):1177-8. PubMed ID: 11203032
    [No Abstract]   [Full Text] [Related]  

  • 67. [Reduction of gastric acid secretion: pathophysiologic and clinically relevant sequelae].
    Koop H; Eissele R
    Z Gastroenterol; 1991 Nov; 29(11):613-7. PubMed ID: 1685286
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fundic gland polyps and PPI: the Mozart effect of gastrointestinal pathology?
    Declich P; Omazzi B; Tavani E; Bellone S; Gozzini C; Bortoli A; Prada A
    Pol J Pathol; 2006; 57(4):181-2. PubMed ID: 17285759
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy.
    Freston JW
    Digestion; 1992; 51 Suppl 1():102-14. PubMed ID: 1397739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Parietal cell protrusions in gastric ulcer disease.
    Krishnamurthy S; Dayal Y
    Hum Pathol; 1997 Oct; 28(10):1126-30. PubMed ID: 9343318
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
    Klinkenberg-Knol EC; Nelis F; Dent J; Snel P; Mitchell B; Prichard P; Lloyd D; Havu N; Frame MH; Romàn J; Walan A;
    Gastroenterology; 2000 Apr; 118(4):661-9. PubMed ID: 10734017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical utility and safety of omeprazole.
    Walan A
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.
    Maton PN; Vinayek R; Frucht H; McArthur KA; Miller LS; Saeed ZA; Gardner JD; Jensen RT
    Gastroenterology; 1989 Oct; 97(4):827-36. PubMed ID: 2777040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Omeprazole induces altered bile acid metabolism.
    Shindo K; Machida M; Fukumura M; Koide K; Yamazaki R
    Gut; 1998 Feb; 42(2):266-71. PubMed ID: 9536953
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
    Nishi T; Makuuchi H; Weinstein WM
    Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Bloemena E; Nelis GF; Festen HP; Jansen EH; Biemond I; Lamers CB; Meuwissen SG
    Aliment Pharmacol Ther; 1998 Jul; 12(7):605-12. PubMed ID: 9701523
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
    Schepp W; Rehner M; Witzel L
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Treatment of gastric ulcers with proton pump inhibitors--long-term treatment].
    Aoki T; Akimoto H; Takayama S
    Nihon Rinsho; 1992 Jan; 50(1):181-7. PubMed ID: 1311784
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relative risk factors associated with the development of fundic gland polyps.
    Huang CZ; Lai RX; Mai L; Zhou HL; Chen HJ; Guo HX
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1217-21. PubMed ID: 25187299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.